Dendritic cells and vaccine design for sexually-transmitted diseases

Dorothee Duluc, Julien Gannevat, HyeMee Joo, Ling Ni, Katherine Upchurch, Muriel Boreham, Michael Carley, Jack Stecher, Gerard Zurawski, SangKon Oh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Dendritic cells (DCs) are major antigen presenting cells (APCs) that can initiate and control host immune responses toward either immunity or tolerance. These features of DCs, as immune orchestrators, are well characterized by their tissue localizations as well as by their subset-dependent functional specialties and plasticity. Thus, the level of protective immunity to invading microbial pathogens can be dependent on the subsets of DCs taking up microbial antigens and their functional plasticity in response to microbial products, host cellular components and the cytokine milieu in the microenvironment.Vaccines are the most efficient and cost-effective preventive medicine against infectious diseases. However, major challenges still remain for the diseases caused by sexually-transmitted pathogens, including HIV, HPV, HSV and Chlamydia. We surmise that the establishment of protective immunity in the female genital mucosa, the major entry and transfer site of these pathogens, will bring significant benefit for the protection against sexually-transmitted diseases. Recent progresses made in DC biology suggest that vaccines designed to target proper DC subsets may permit us to establish protective immunity in the female genital mucosa against sexually-transmitted pathogens.

Original languageEnglish (US)
Pages (from-to)35-44
Number of pages10
JournalMicrobial Pathogenesis
Volume58
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Sexually Transmitted Diseases
Dendritic Cells
Vaccines
Immunity
Mucous Membrane
Preventive Medicine
Chlamydia
Antigen-Presenting Cells
Communicable Diseases
Cell Biology
HIV
Cytokines
Antigens
Costs and Cost Analysis

Keywords

  • Dendritic cells
  • Genital
  • Mucosa
  • Sexually-transmitted diseases
  • Vaccines

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

Dendritic cells and vaccine design for sexually-transmitted diseases. / Duluc, Dorothee; Gannevat, Julien; Joo, HyeMee; Ni, Ling; Upchurch, Katherine; Boreham, Muriel; Carley, Michael; Stecher, Jack; Zurawski, Gerard; Oh, SangKon.

In: Microbial Pathogenesis, Vol. 58, 01.01.2013, p. 35-44.

Research output: Contribution to journalArticle

Duluc, D, Gannevat, J, Joo, H, Ni, L, Upchurch, K, Boreham, M, Carley, M, Stecher, J, Zurawski, G & Oh, S 2013, 'Dendritic cells and vaccine design for sexually-transmitted diseases', Microbial Pathogenesis, vol. 58, pp. 35-44. https://doi.org/10.1016/j.micpath.2012.11.010
Duluc, Dorothee ; Gannevat, Julien ; Joo, HyeMee ; Ni, Ling ; Upchurch, Katherine ; Boreham, Muriel ; Carley, Michael ; Stecher, Jack ; Zurawski, Gerard ; Oh, SangKon. / Dendritic cells and vaccine design for sexually-transmitted diseases. In: Microbial Pathogenesis. 2013 ; Vol. 58. pp. 35-44.
@article{aa48e75b87334e1aac255a02f4ba6857,
title = "Dendritic cells and vaccine design for sexually-transmitted diseases",
abstract = "Dendritic cells (DCs) are major antigen presenting cells (APCs) that can initiate and control host immune responses toward either immunity or tolerance. These features of DCs, as immune orchestrators, are well characterized by their tissue localizations as well as by their subset-dependent functional specialties and plasticity. Thus, the level of protective immunity to invading microbial pathogens can be dependent on the subsets of DCs taking up microbial antigens and their functional plasticity in response to microbial products, host cellular components and the cytokine milieu in the microenvironment.Vaccines are the most efficient and cost-effective preventive medicine against infectious diseases. However, major challenges still remain for the diseases caused by sexually-transmitted pathogens, including HIV, HPV, HSV and Chlamydia. We surmise that the establishment of protective immunity in the female genital mucosa, the major entry and transfer site of these pathogens, will bring significant benefit for the protection against sexually-transmitted diseases. Recent progresses made in DC biology suggest that vaccines designed to target proper DC subsets may permit us to establish protective immunity in the female genital mucosa against sexually-transmitted pathogens.",
keywords = "Dendritic cells, Genital, Mucosa, Sexually-transmitted diseases, Vaccines",
author = "Dorothee Duluc and Julien Gannevat and HyeMee Joo and Ling Ni and Katherine Upchurch and Muriel Boreham and Michael Carley and Jack Stecher and Gerard Zurawski and SangKon Oh",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.micpath.2012.11.010",
language = "English (US)",
volume = "58",
pages = "35--44",
journal = "Microbial Pathogenesis",
issn = "0882-4010",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Dendritic cells and vaccine design for sexually-transmitted diseases

AU - Duluc, Dorothee

AU - Gannevat, Julien

AU - Joo, HyeMee

AU - Ni, Ling

AU - Upchurch, Katherine

AU - Boreham, Muriel

AU - Carley, Michael

AU - Stecher, Jack

AU - Zurawski, Gerard

AU - Oh, SangKon

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Dendritic cells (DCs) are major antigen presenting cells (APCs) that can initiate and control host immune responses toward either immunity or tolerance. These features of DCs, as immune orchestrators, are well characterized by their tissue localizations as well as by their subset-dependent functional specialties and plasticity. Thus, the level of protective immunity to invading microbial pathogens can be dependent on the subsets of DCs taking up microbial antigens and their functional plasticity in response to microbial products, host cellular components and the cytokine milieu in the microenvironment.Vaccines are the most efficient and cost-effective preventive medicine against infectious diseases. However, major challenges still remain for the diseases caused by sexually-transmitted pathogens, including HIV, HPV, HSV and Chlamydia. We surmise that the establishment of protective immunity in the female genital mucosa, the major entry and transfer site of these pathogens, will bring significant benefit for the protection against sexually-transmitted diseases. Recent progresses made in DC biology suggest that vaccines designed to target proper DC subsets may permit us to establish protective immunity in the female genital mucosa against sexually-transmitted pathogens.

AB - Dendritic cells (DCs) are major antigen presenting cells (APCs) that can initiate and control host immune responses toward either immunity or tolerance. These features of DCs, as immune orchestrators, are well characterized by their tissue localizations as well as by their subset-dependent functional specialties and plasticity. Thus, the level of protective immunity to invading microbial pathogens can be dependent on the subsets of DCs taking up microbial antigens and their functional plasticity in response to microbial products, host cellular components and the cytokine milieu in the microenvironment.Vaccines are the most efficient and cost-effective preventive medicine against infectious diseases. However, major challenges still remain for the diseases caused by sexually-transmitted pathogens, including HIV, HPV, HSV and Chlamydia. We surmise that the establishment of protective immunity in the female genital mucosa, the major entry and transfer site of these pathogens, will bring significant benefit for the protection against sexually-transmitted diseases. Recent progresses made in DC biology suggest that vaccines designed to target proper DC subsets may permit us to establish protective immunity in the female genital mucosa against sexually-transmitted pathogens.

KW - Dendritic cells

KW - Genital

KW - Mucosa

KW - Sexually-transmitted diseases

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84875872109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875872109&partnerID=8YFLogxK

U2 - 10.1016/j.micpath.2012.11.010

DO - 10.1016/j.micpath.2012.11.010

M3 - Article

C2 - 23201532

AN - SCOPUS:84875872109

VL - 58

SP - 35

EP - 44

JO - Microbial Pathogenesis

JF - Microbial Pathogenesis

SN - 0882-4010

ER -